Sugar Maple Asset Management LLC Acquires New Shares in U.S. Physical Therapy, Inc. (NYSE:USPH)

Sugar Maple Asset Management LLC bought a new position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,500 shares of the company’s stock, valued at approximately $212,000.

A number of other large investors have also recently made changes to their positions in USPH. Silvercrest Asset Management Group LLC bought a new stake in shares of U.S. Physical Therapy during the 1st quarter valued at $8,158,000. Harbor Capital Advisors Inc. increased its position in shares of U.S. Physical Therapy by 292.5% during the second quarter. Harbor Capital Advisors Inc. now owns 7,584 shares of the company’s stock valued at $701,000 after buying an additional 5,652 shares during the period. Vanguard Group Inc. lifted its holdings in shares of U.S. Physical Therapy by 1.0% in the first quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company’s stock worth $121,065,000 after buying an additional 10,175 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its position in shares of U.S. Physical Therapy by 5.8% in the first quarter. CANADA LIFE ASSURANCE Co now owns 12,642 shares of the company’s stock valued at $1,423,000 after acquiring an additional 696 shares during the period. Finally, First Horizon Advisors Inc. boosted its position in shares of U.S. Physical Therapy by 18.6% in the second quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company’s stock valued at $110,000 after acquiring an additional 186 shares during the period.

Insiders Place Their Bets

In other news, Director Nancy Ham sold 1,172 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $96.72, for a total value of $113,355.84. Following the sale, the director now directly owns 1,112 shares in the company, valued at approximately $107,552.64. This trade represents a 51.31 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Graham D. Reeve sold 1,724 shares of the firm’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at $580,635. The trade was a 19.68 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 8,620 shares of company stock valued at $799,170 over the last three months. Insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Price Performance

USPH stock opened at $90.00 on Friday. The firm has a 50 day simple moving average of $84.19 and a two-hundred day simple moving average of $91.09. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.88. The stock has a market cap of $1.36 billion, a PE ratio of 95.74, a P/E/G ratio of 4.07 and a beta of 1.38. U.S. Physical Therapy, Inc. has a one year low of $76.18 and a one year high of $113.63.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 15th will be paid a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 1.96%. The ex-dividend date is Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 187.23%.

Analysts Set New Price Targets

Several research analysts have commented on USPH shares. Bank of America reissued a “neutral” rating and issued a $90.00 price target (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Finally, Barrington Research restated an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research note on Thursday, November 7th.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.